Acute Exacerbation of Idiopathic Pulmonary Fibrosis
AbstractIdiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonia. Idiopathic pulmonary fibrosis is often seen in elderly men who smoke. A diagnosis of IPF is based on a combination of a detailed clinical history, specific physical examination, laboratory findings, pulmonary function tests, high-resolution computed tomography (HRCT) of the chest, and histopathology. Idiopathic pulmonary fibrosis has a heterogeneous clinical course, from an asymptomatic stable state to progressive respiratory failure or acute exacerbation (AE). Acute exacerbation of IPF has several important differential diagnoses, such as heart failure and volume overload. The International Working Group project proposed new criteria for defining AE of IPF in 2016, which divides it into triggered and idiopathic AE. On the basis of these criteria, physicians can detect AE of IPF more easily. The recent international IPF guidelines emphasized the utility of chest HRCT. In addition, two antifibrotic agents have become available. We should focus on both the management and prevention of AE. The diagnostic process, laboratory findings, typical chest imaging, management, and prognosis of AE are comprehensively reviewed in this article. View Full-Text
Share & Cite This Article
Kishaba, T. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Medicina 2019, 55, 70.
Kishaba T. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Medicina. 2019; 55(3):70.Chicago/Turabian Style
Kishaba, Tomoo. 2019. "Acute Exacerbation of Idiopathic Pulmonary Fibrosis." Medicina 55, no. 3: 70.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.